Bukwang Pharmaceutical Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was KRW 0.00023 million compared to KRW 0.00001 million a year ago. Net loss was KRW 421.4 million compared to KRW 266.51 million a year ago. Basic loss per share from continuing operations was KRW 6 compared to KRW 4 a year ago. Diluted loss per share from continuing operations was KRW 5 compared to KRW 4 a year ago. Basic loss per share was KRW 6 compared to KRW 4 a year ago.
For the six months, negative sales was KRW 0.00092 million compared to sales of KRW 0.00001 million a year ago. Net loss was KRW 2,541.82 million compared to KRW 3,482.98 million a year ago. Basic loss per share from continuing operations was KRW 37 compared to KRW 51 a year ago. Diluted loss per share from continuing operations was KRW 37 compared to KRW 51 a year ago. Basic loss per share was KRW 37 compared to KRW 51 a year ago.